Partnership for Research on Ebola VACcinations
Condition: Ebola Virus Disease Interventions: Biological: Ad26.ZEBOV; Biological: MVA-BN-Filo; Biological: rVSVΔG-ZEBOV-GP; Biological: Placebo; Biological: rVSV boost Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); The Liberia-US Clinical Trials Partnership Program, Partnership for Research on Ebola Virus in Liberia Project (PREVAIL); Institut National de la Santé Et de la Recherche Médicale, France; London School of Hygiene& Tropical Medicine (LSHTM) Not yet recruiting - verified August 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Clinical Trials | Ebola | Ebola Vaccine | Infectious Diseases | Partnerships | Research | Tropical Medicine | Vaccines